Literature DB >> 22349875

Nociceptive pathway function is normal in cervical dystonia: a study using laser-evoked potentials.

Michele Tinazzi1, Massimiliano Valeriani, Giovanna Squintani, Federica Corrà, Serena Recchia, Giovanni Defazio, Alfredo Berardelli.   

Abstract

Cervical dystonia (CD) is often associated with pain in the neck muscles, though the mechanisms underlying pain in this condition are still largely unknown. The aim of this study was to assess laser pain rating and CO(2) laser-evoked potentials (LEPs) in CD patients with pain in the posterior neck region. We assessed the N2/P2 LEP complex and laser pain rating in a group of 20 CD patients and in 21 normal subjects. In 11 of the 20 CD patients (group I), the N2/P2 complex was recorded after stimulation of the skin overlying the right and left deltoid muscles (painless and non-dystonic). In the remaining nine CD patients (group II), the N2/P2 complex was recorded after stimulation of the skin over the splenius capitis muscle (painful and dystonic) and after stimulation of the skin overlying the contralateral splenius muscle (painless and non-dystonic). In group I patients, the N2/P2 LEP amplitude and laser pain rating after stimulation of both shoulders did not differ significantly from those obtained in normal subjects. Similarly, in group II patients, the N2/P2 LEP amplitude and laser pain rating after stimulation of the painful and dystonic splenius capitis muscle did not differ significantly from those obtained from either the contralateral painless, non-dystonic splenius capitis or normal subjects. The results of this study demonstrate that cutaneous nociceptive pathway function in CD patients is normal, thereby indicating that muscle pain in CD is not associated with any central sensitization of nociceptive inputs in either painful (dystonic) or non-painful (non-dystonic) body areas.

Entities:  

Mesh:

Year:  2012        PMID: 22349875     DOI: 10.1007/s00415-012-6454-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  46 in total

Review 1.  Clinical usefulness of laser-evoked potentials.

Authors:  Rolf-Detlef Treede; Jürgen Lorenz; Ulf Baumgärtner
Journal:  Neurophysiol Clin       Date:  2003-12       Impact factor: 3.734

Review 2.  Botulinum toxin for pain.

Authors:  Roberto Casale; Valeria Tugnoli
Journal:  Drugs R D       Date:  2008

3.  Scalp topography and dipolar source modelling of potentials evoked by CO2 laser stimulation of the hand.

Authors:  M Valeriani; L Rambaud; F Mauguière
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1996-07

4.  Laser-evoked potentials after painful hand and foot stimulation in humans: evidence for generation of the middle-latency component in the secondary somatosensory cortex.

Authors:  J Spiegel; C Hansen; R D Treede
Journal:  Neurosci Lett       Date:  1996-10-04       Impact factor: 3.046

5.  Abnormal central integration of a dual somatosensory input in dystonia. Evidence for sensory overflow.

Authors:  M Tinazzi; A Priori; L Bertolasi; E Frasson; F Mauguière; A Fiaschi
Journal:  Brain       Date:  2000-01       Impact factor: 13.501

6.  Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double-blind study on twenty-three patients.

Authors:  I T Lorentz; S S Subramaniam; C Yiannikas
Journal:  Mov Disord       Date:  1991       Impact factor: 10.338

7.  Epidemiology of dystonia in Rochester, Minnesota.

Authors:  J G Nutt; M D Muenter; L J Melton; A Aronson; L T Kurland
Journal:  Adv Neurol       Date:  1988

Review 8.  Dystonia.

Authors:  S B Bressman
Journal:  Curr Opin Neurol       Date:  1998-08       Impact factor: 5.710

9.  Anatomy and physiology of a nociceptive modulatory system.

Authors:  H L Fields; M M Heinricher
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1985-02-19       Impact factor: 6.237

10.  Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis.

Authors:  D J Gelb; D H Lowenstein; M J Aminoff
Journal:  Neurology       Date:  1989-01       Impact factor: 9.910

View more
  6 in total

1.  The Use of Botulinum Toxin for Treatment of the Dystonias.

Authors:  Alfredo Berardelli; Antonella Conte
Journal:  Handb Exp Pharmacol       Date:  2021

Review 2.  Pain in Neurodegenerative Disease: Current Knowledge and Future Perspectives.

Authors:  Marina de Tommaso; Lars Arendt-Nielsen; Ruth Defrin; Miriam Kunz; Gisele Pickering; Massimiliano Valeriani
Journal:  Behav Neurol       Date:  2016-06-05       Impact factor: 3.342

3.  Abnormal regional homogeneity and its relationship with symptom severity in cervical dystonia: a rest state fMRI study.

Authors:  Shubao Wei; Chunhui Lu; Xiuqiong Chen; Lu Yang; Jing Wei; Wenyan Jiang; Yang Liu; Hui Hui Li; Yuhong Qin; Yiwu Lei; Chao Qin; Caiyou Hu; Shuguang Luo
Journal:  BMC Neurol       Date:  2021-02-05       Impact factor: 2.474

Review 4.  The role of sensory information in the pathophysiology of focal dystonias.

Authors:  Antonella Conte; Giovanni Defazio; Mark Hallett; Giovanni Fabbrini; Alfredo Berardelli
Journal:  Nat Rev Neurol       Date:  2019-04       Impact factor: 42.937

Review 5.  Advances in the pathophysiology of adult-onset focal dystonias: recent neurophysiological and neuroimaging evidence.

Authors:  Antonella Conte; Giovanni Defazio; Marcello Mascia; Daniele Belvisi; Patrizia Pantano; Alfredo Berardelli
Journal:  F1000Res       Date:  2020-01-30

6.  Non-motor phenotypic subgroups in adult-onset idiopathic, isolated, focal cervical dystonia.

Authors:  Megan E Wadon; Grace A Bailey; Zehra Yilmaz; Emily Hubbard; Meshari AlSaeed; Amy Robinson; Duncan McLauchlan; Richard L Barbano; Laura Marsh; Stewart A Factor; Susan H Fox; Charles H Adler; Ramon L Rodriguez; Cynthia L Comella; Stephen G Reich; William L Severt; Christopher G Goetz; Joel S Perlmutter; Hyder A Jinnah; Katharine E Harding; Cynthia Sandor; Kathryn J Peall
Journal:  Brain Behav       Date:  2021-07-21       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.